Inhibrx Biosciences, Inc. (INXB) Stock Analysis
DELISTED
What happened to Inhibrx Biosciences, Inc. (INXB) stock?
Inhibrx Biosciences, Inc. (INXB) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $226M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Inhibrx Biosciences, Inc. (INXB). Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing advanced biologic treatments for critical, life-threatening medical conditions.
Last analyzed: Jun 15, 2026Inhibrx Biosciences, Inc. (INXB) Healthcare & Pipeline Overview
Inhibrx Biosciences, Inc. ADR Information Sponsored
Inhibrx Biosciences, Inc. (INXB) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy INXB shares?
No. INXB stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for INXB elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before INXB stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Inhibrx Biosciences, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.